Diretrizes internacionais

Restante do mundo

Molnupiravir for treating COVID-19[682]

Publicada por:National Institute for Health and Care Excellence (UK)

Última publicação:2025

Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19[681]

Publicada por:National Institute for Health and Care Excellence (UK)

Última publicação:2025

COVID-19 rapid guideline: managing COVID-19[405]

Publicada por:National Institute for Health and Care Excellence (UK)

Última publicação:2025

COVID-19: clinical considerations for special populations[888]

Publicada por:Centers for Disease Control and Prevention

Última publicação:2025

Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19[401]

Publicada por:Infectious Diseases Society of America

Última publicação:2025

Interim clinical considerations for use of COVID-19 vaccines in the United States[890]

Publicada por:Centers for Disease Control and Prevention

Última publicação:2025

CDC yellow book: health information for international travel - COVID-19[889]

Publicada por:Centers for Disease Control and Prevention

Última publicação:2025

Therapeutics and COVID-19: living guideline[406]

Publicada por:World Health Organization

Última publicação:2025

COVID-19: the green book, chapter 14a[893]

Publicada por:UK Health Security Agency

Última publicação:2025

Clinical management of COVID-19: living guideline[444]

Publicada por:World Health Organization

Última publicação:2025

COVID-19 treatment clinical care for outpatients[887]

Publicada por:Centers for Disease Control and Prevention

Última publicação:2025

COVID-19 outbreak toolbox[892]

Publicada por:World Health Organization

Última publicação:2024

Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: serologic testing[507]

Publicada por:Infectious Diseases Society of America

Última publicação:2024

COVID-19: clinical course - progression, management, and treatment[670]

Publicada por:Centers for Disease Control and Prevention

Última publicação:2024

Remdesivir and tixagevimab plus cilgavimab for treating COVID-19[701]

Publicada por:National Institute for Health and Care Excellence (UK)

Última publicação:2024

Infection control guidance: SARS-CoV-2[665]

Publicada por:Centers for Disease Control and Prevention

Última publicação:2024

Coronavirus (COVID-19): guidance[667]

Publicada por:UK Health Security Agency

Última publicação:2024

Overview of testing for SARS-CoV-2[442]

Publicada por:Centers for Disease Control and Prevention

Última publicação:2024

Coronavirus disease 2019 (COVID-19)[894]

Publicada por:Australian Government Department of Health and Aged Care; Australian Centre for Disease Control

Última publicação:2024

Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: molecular diagnostic testing[614]

Publicada por:Infectious Diseases Society of America

Última publicação:2023

Drugs to prevent COVID-19: WHO living guideline[404]

Publicada por:World Health Organization

Última publicação:2023

Public health surveillance for COVID-19: interim guidance[124]

Publicada por:World Health Organization

Última publicação:2022 (addendum 2023)

ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2​​[668]

Publicada por:European Society of Clinical Microbiology and Infectious Diseases

Última publicação:2022

Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing[503]

Publicada por:World Health Organization

Última publicação:2022

Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: antigen testing[615]

Publicada por:Infectious Diseases Society of America

Última publicação:2022

Coronavirus (COVID-19) infection in pregnancy[896]

Publicada por:Royal College of Obstetricians and Gynaecologists (UK)

Última publicação:2022

European Society of Clinical Microbiology and Infectious Diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease[895]

Publicada por:European Society of Clinical Microbiology and Infectious Diseases

Última publicação:2022

Care for adults with COVID-19: living guidelines[897]

Publicada por:Australian National COVID-19 Clinical Evidence Taskforce

Última publicação:2022

Infectious Diseases Society of America guidelines on infection prevention for healthcare personnel caring for patients with suspected or known COVID-19[666]

Publicada por:Infectious Diseases Society of America

Последняя публикация:2021

Antigen-detection in the diagnosis of SARS-CoV-2 infection: interim guidance[440]

Опубликовано:World Health Organization

Последняя публикация:2021

Surviving Sepsis Campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU[715]

Опубликовано:Surviving Sepsis Campaign

Последняя публикация:2021

Prevention and management of venous thromboembolism in patients with COVID-19[898]

Опубликовано:Scottish Intercollegiate Guidelines Network

Последняя публикация:2021

Management of hospitalised adults with coronavirus disease 2019 (COVID-19)[899]

Опубликовано:European Respiratory Society

Последняя публикация:2021

Diagnostic testing for SARS-CoV-2: interim guidance[439]

Опубликовано:World Health Organization

Последняя публикация:2020

Use of chest imaging in COVID-19: a rapid advice guide[544]

Опубликовано:World Health Organization

Последняя публикация:2020

Home care for patients with suspected or confirmed COVID-19 and management of their contacts: interim guidance[669]

Опубликовано:World Health Organization

Последняя публикация:2020

Использование этого контента попадает под действие нашего заявления об отказе от ответственности